Recent News

• 06.04.2025 - Jefferies Global Healthcare Conference 2025
• 06.04.2025 - Jefferies Global Healthcare Conference 2025
• 06.03.2025 - William Blair 45th Annual Growth Stock Conference
• 06.03.2025 - William Blair 45th Annual Growth Stock Conference
• 05.27.2025 - TD Cowen 6th Annual Oncology Innovation Summit
• 05.27.2025 - TD Cowen 6th Annual Oncology Innovation Summit
• 05.22.2025 - Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ASCO 2025
• 05.22.2025 - Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ASCO 2025
• 05.22.2025 - Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May and June
• 05.22.2025 - Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May and June

Recent Filings

• 05.21.2025 - 144 Report of proposed sale of securities
• 05.20.2025 - 144 Report of proposed sale of securities
• 05.20.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities